Idenix Pharmaceuticals competitive analysis

Explore Idenix Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 1, 20172-Branched Nucleosides And Flaviviridae Mutation1
Apr 29, 2015Modified 2' And 3'-Nucleoside Prodrugs For Treating Flaviridae Infections2

Latest PTAB cases involving Idenix Pharmaceuticals

Discover the latest PTAB cases involving Idenix Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Idenix Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IDENIX PHARMACEUTICALS - 3 - -
GILEAD SCIENCES76386